363 KEYNOTE-042 5-year survival update: pembrolizumab versus chemotherapy in patients with previously untreated, PD-L1–positive, locally advanced or metastatic non–small-cell lung cancer
| Autor: | Li Zhang, Kaoru Kubota, Yi-Long Wu, Byoung Chul Cho, Gilberto de Castro, Iveta Kudaba, Gilberto Lopes, Dariusz M Kowalski, Hande Z Turna, Christian Caglevic, Boguslawa Karaszewska, Konstantin K Laktionov, Vichien Srimuninnimit, Igor Bondarenko, Rinee Mukherjee, Jianxin Lin, Fabricio Souza, Tony SK Mok |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2021-SITC2021.363 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|